[HTML][HTML] The potential of short-chain fatty acid epigenetic regulation in chronic low-grade inflammation and obesity
J Kopczyńska, M Kowalczyk - Frontiers in Immunology, 2024 - frontiersin.org
Obesity and chronic low-grade inflammation, often occurring together, significantly
contribute to severe metabolic and inflammatory conditions like type 2 diabetes (T2D) …
contribute to severe metabolic and inflammatory conditions like type 2 diabetes (T2D) …
Advancements in the management of obesity: a review of current evidence and emerging therapies
MA Abdalla Ahmed, E Ssemmondo… - Expert Review of …, 2024 - Taylor & Francis
Introduction Obesity is the modern world's current epidemic, with substantial health and
economic impact. This study aimed to provide a narrative overview of the past, currently …
economic impact. This study aimed to provide a narrative overview of the past, currently …
Systemic Co-Administration of Low-Dose Oxytocin and Glucagon-Like Peptide 1 Additively Decreases Food Intake and Body Weight
Y Maejima, S Yokota, S Hidema, K Nishimori… - …, 2024 - karger.com
Introduction: GLP-1 receptor agonists are the number one drug prescribed for the treatment
of obesity and type 2 diabetes. These drugs are not, however, without side effects, and in an …
of obesity and type 2 diabetes. These drugs are not, however, without side effects, and in an …